Investing.com - Shockwave Medical (NASDAQ: SWAV) reported first quarter EPS of $1.03, $0.24 better than the analyst estimate of $0.79. Revenue for the quarter came in at $161.1M versus the consensus estimate of $147.3M.
Guidance
Shockwave Medical sees FY 2023 revenue of $700.00M-$720.00M versus the analyst consensus of $672.00M.
Shockwave Medical's stock price closed at $274.96. It is up 52.65% in the last 3 months and up 137.22% in the last 12 months.
Shockwave Medical saw 3 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Shockwave Medical's stock price’s past reactions to earnings here.
According to InvestingPro, Shockwave Medical's Financial Health score is "excellent performance".
Check out Shockwave Medical's recent earnings performance, and Shockwave Medical's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar